Home
/
INTUITIVE SURGICAL INC
/
Financials
/
Quarterly
INTUITIVE SURGICAL INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INTUITIVE SURGICAL INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.51B
Oct 22, 2025
Q2
2025
Jun 30, 2025
$2.44B
Jul 23, 2025
Q1
2025
Mar 31, 2025
$2.25B
Apr 23, 2025
Q3
2025
Sep 30, 2024
$2.04B
Oct 22, 2025
Q2
2025
Jun 30, 2024
$2.01B
Jul 23, 2025
Q1
2025
Mar 31, 2024
$1.89B
Apr 23, 2025
Q3
2024
Sep 30, 2023
$1.74B
Oct 18, 2024
Q2
2024
Jun 30, 2023
$1.76B
Jul 19, 2024
Q1
2024
Mar 31, 2023
$1.70B
Apr 19, 2024
Q3
2023
Sep 30, 2022
$1.56B
Oct 20, 2023
Q2
2023
Jun 30, 2022
$1.52B
Jul 24, 2023
Q1
2023
Mar 31, 2022
$1.49B
Apr 20, 2023
Q3
2022
Sep 30, 2021
$1.40B
Oct 21, 2022
Q2
2022
Jun 30, 2021
$1.46B
Jul 22, 2022
Q1
2022
Mar 31, 2021
$1.29B
Apr 22, 2022
Q3
2021
Sep 30, 2020
$1.08B
Oct 20, 2021
Q2
2021
Jun 30, 2020
$852.10M
Jul 21, 2021
Q1
2021
Mar 31, 2020
$1.10B
Apr 21, 2021
Q3
2020
Sep 30, 2019
$1.13B
Oct 19, 2020
Q2
2020
Jun 30, 2019
$1.10B
Jul 23, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$909.30M
Jul 20, 2018
Q1
2018
Mar 31, 2018
$847.50M
Apr 18, 2018
Q3
2017
Sep 30, 2017
$806.10M
Oct 20, 2017
Q2
2018
Jun 30, 2017
$758.80M
Jul 20, 2018
Q1
2018
Mar 31, 2017
$679.60M
Apr 18, 2018
Q3
2017
Sep 30, 2016
$682.90M
Oct 20, 2017
Q2
2017
Jun 30, 2016
$670.10M
Jul 21, 2017
Q1
2017
Mar 31, 2016
$594.50M
Apr 19, 2017
Q3
2016
Sep 30, 2015
$589.70M
Oct 19, 2016
Q2
2016
Jun 30, 2015
$586.10M
Jul 20, 2016
Q1
2016
Mar 31, 2015
$532.10M
Apr 19, 2016
Q3
2015
Sep 30, 2014
$550.10M
Oct 21, 2015
Q2
2015
Jun 30, 2014
$512.20M
Jul 22, 2015
Q1
2015
Mar 31, 2014
$464.70M
Apr 22, 2015
Q3
2014
Sep 30, 2013
$499.00M
Oct 23, 2014
Q2
2014
Jun 30, 2013
$578.50M
Jul 24, 2014
Q1
2014
Mar 31, 2013
$611.40M
Apr 25, 2014
Q3
2013
Sep 30, 2012
$537.80M
Oct 18, 2013
Q2
2013
Jun 30, 2012
$536.50M
Jul 22, 2013
Q1
2013
Mar 31, 2012
$495.20M
Apr 19, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$704.40M
Oct 22, 2025
Q2
2025
Jun 30, 2025
$658.40M
Jul 23, 2025
Q1
2025
Mar 31, 2025
$698.40M
Apr 23, 2025
Q3
2025
Sep 30, 2024
$565.10M
Oct 22, 2025
Q2
2025
Jun 30, 2024
$526.90M
Jul 23, 2025
Q1
2025
Mar 31, 2024
$544.90M
Apr 23, 2025
Q3
2024
Sep 30, 2023
$415.70M
Oct 18, 2024
Q2
2024
Jun 30, 2023
$420.80M
Jul 19, 2024
Q1
2024
Mar 31, 2023
$355.30M
Apr 19, 2024
Q3
2023
Sep 30, 2022
$324.00M
Oct 20, 2023
Q2
2023
Jun 30, 2022
$307.80M
Jul 24, 2023
Q1
2023
Mar 31, 2022
$365.60M
Apr 20, 2023
Q3
2022
Sep 30, 2021
$380.50M
Oct 21, 2022
Q2
2022
Jun 30, 2021
$517.20M
Jul 22, 2022
Q1
2022
Mar 31, 2021
$426.30M
Apr 22, 2022
Q3
2021
Sep 30, 2020
$313.90M
Oct 20, 2021
Q2
2021
Jun 30, 2020
$68.00M
Jul 21, 2021
Q1
2021
Mar 31, 2020
$313.50M
Apr 21, 2021
Q3
2020
Sep 30, 2019
$396.80M
Oct 19, 2020
Q2
2020
Jun 30, 2019
$318.30M
Jul 23, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$759.70M
Oct 22, 2025
Q2
2025
Jun 30, 2025
$743.40M
Jul 23, 2025
Q1
2025
Mar 31, 2025
$578.10M
Apr 23, 2025
Q3
2025
Sep 30, 2024
$577.30M
Oct 22, 2025
Q2
2025
Jun 30, 2024
$567.30M
Jul 23, 2025
Q1
2025
Mar 31, 2024
$469.40M
Apr 23, 2025
Q3
2024
Sep 30, 2023
$465.80M
Oct 18, 2024
Q2
2024
Jun 30, 2023
$463.20M
Jul 19, 2024
Q1
2024
Mar 31, 2023
$387.60M
Apr 19, 2024
Q3
2023
Sep 30, 2022
$398.90M
Oct 20, 2023
Q2
2023
Jun 30, 2022
$397.60M
Jul 24, 2023
Q1
2023
Mar 31, 2022
$408.10M
Apr 20, 2023
Q3
2022
Sep 30, 2021
$442.60M
Oct 21, 2022
Q2
2022
Jun 30, 2021
$511.20M
Jul 22, 2022
Q1
2022
Mar 31, 2021
$416.80M
Apr 22, 2022
Q3
2021
Sep 30, 2020
$270.40M
Oct 20, 2021
Q2
2021
Jun 30, 2020
$80.60M
Jul 21, 2021
Q1
2021
Mar 31, 2020
$283.00M
Apr 21, 2021
Q3
2020
Sep 30, 2019
$365.70M
Oct 19, 2020
Q2
2020
Jun 30, 2019
$359.00M
Jul 23, 2020